National Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Pediatric Leukemia and Lymphoma Steering Committee

The Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) was established in 2011. PLLSC members include representatives from the Children's Oncology Group, pediatric and medical oncologists and other specialists, translational scientists, biostatisticians, patient advocates, and NCI staff.

Mission Statement

The PLLSC follows a data-driven, transparent process to identify and promote the best science in clinical research for pediatric and adolescent patients with leukemia, lymphoma, and other hematologic malignancies by evaluating and prioritizing phase II and phase III clinical trial concepts.

Roster of Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) members
David Poplack, M.D. - Chair; Robert Arceci, M.D., Ph.D. - Vice Chair

Clinical Trial Planning Meetings (CTPMs): Goal of Clinical Trial Planning Meetings, and List of CTPM Executive Summaries and Publications

CCCT Contact: Wolf Lindwasser, Ph.D.